Mapping the differences in cancer tumors for better treatment
TRD 1 - Imaging Cancer Heterogeneity
This study is exploring new imaging methods to create detailed 3D maps of tumors in brain, prostate, and gynecological cancers, helping doctors understand the unique features of each tumor so they can tailor treatments to improve outcomes for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10992167 on NIH RePORTER |
What this research studies
This research focuses on improving cancer treatment by using advanced imaging techniques to understand the differences within tumors. It aims to create detailed 3D maps of tumor composition, particularly in brain, prostate, and gynecological cancers, to better define tumor boundaries and guide personalized treatment plans. By characterizing tumor heterogeneity, the research seeks to enhance the precision of cancer therapies and improve patient outcomes. The project will develop and validate new imaging technologies that can be applied to various types of cancers.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with brain, prostate, or gynecological cancers who are seeking personalized treatment options.
Not a fit: Patients with cancers not included in the initial focus, or those who do not require imaging for treatment planning, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized cancer treatments by accurately identifying tumor characteristics.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for cancer characterization, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Agar, Nathalie Yr — Brigham and Women's Hospital
- Study coordinator: Agar, Nathalie Yr
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.